Embecta (MEX:EMBC) Other Current Payables: MXN0 Mil (As of Mar. 2026)


MEX:EMBC Embecta Corp MEX:EMBC
53 GF Score
Price MXN497.96
GF Value MXN1,884.82
! 6 Warning Signs
View Full Analysis

What is Embecta Other Current Payables?

Embecta MEX:EMBC 53 Other Current Payables is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:EMBC with a GF Score™ of 53/100 and a GF Value™ of MXN1,884.82. The stock has 6 warning signs investors should review.

Embecta's Other Current Payables for the quarter that ended in Mar. 2026 was MXN0 Mil.

Embecta's quarterly Other Current Payables declined from Sep. 2025 (MXN299 Mil) to Dec. 2025 (MXN0 Mil) but then stayed the same from Dec. 2025 (MXN0 Mil) to Mar. 2026 (MXN0 Mil).

Embecta's annual Other Current Payables declined from Sep. 2023 (MXN1,273 Mil) to Sep. 2024 (MXN837 Mil) and declined from Sep. 2024 (MXN837 Mil) to Sep. 2025 (MXN299 Mil).

Embecta Other Current Payables Related Terms

Embecta Other Current Payables Historical Data

* Premium members only.

The historical data trend for Embecta's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta Other Current Payables Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Payables
Get a 7-Day Free Trial 0.00 1,337.65 1,273.32 836.84 299.01

Embecta Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 423.49 367.17 299.01 0.00 0.00
MEX:EMBC
53GF Score
Embecta Corp MEX:EMBC
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embecta Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of MXN0 Mil mean?
Embecta (MEX:EMBC) has a Other Current Payables of MXN0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Embecta and its competitors.
Is Embecta's Other Current Payables too high?
Embecta's current Other Current Payables is MXN0 Mil. Overall, Embecta has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Embecta's Other Current Payables compare to KRMD and SMTI?
Embecta's Other Current Payables of MXN0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Embecta and its competitors. Embecta's current Other Current Payables is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Embecta (MEX:EMBC) has a current Other Current Payables of MXN0 Mil. The stock's GF Value™ is MXN1,884.82, compared to a current price of MXN497.96 — trading 73.6% below its estimated fair value. The current Other Current Payables is MXN0 Mil. Embecta's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Embecta (MEX:EMBC), the current Other Current Payables is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embecta (MEX:EMBC) Overvalued in 2026?

Based on GuruFocus' analysis, Embecta stock appears to be undervalued. The current stock price of MXN497.96 is trading 73.6% below its estimated GF Value™ of MXN1,884.82.

Key valuation signals for MEX:EMBC:

  • Other Current Payables: MXN0 Mil
  • GF Value™: MXN1,884.82 vs. price of MXN497.96 (73.6% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the MEX:EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embecta Business Description

Other Exchanges EMBC:USAJX7:Germany
Address 300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score

Get the complete analysis for MEX:EMBC

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN497.96
Price
MXN1,884.82
GF Value